SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that ...

Insilico Medicine("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), ...

Two UBC Southern Medical Program (SMP) graduates are helping change how cancer survivors receive follow-up care in rural BC, ...

Though caution is required when the data haven't been published, it could be a landmark in the drug's journey toward FDA ...

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after ...

Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...